- Home
- TRC vs ZVRA Comparison
TRC vs ZVRA Comparison
Compare TRC & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRC | ZVRA |
|---|---|---|
| Founded | 1843 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.6M | 499.4M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | TRC | ZVRA |
|---|---|---|
| Price | $15.81 | $8.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.71 |
| AVG Volume (30 Days) | 100.6K | ★ 882.9K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.11 | ★ 0.54 |
| Revenue | $46,420,000.00 | ★ $84,388,000.00 |
| Revenue This Year | $2.31 | $333.25 |
| Revenue Next Year | N/A | $43.70 |
| P/E Ratio | $144.07 | ★ $15.78 |
| Revenue Growth | 15.71 | ★ 244.60 |
| 52 Week Low | $14.90 | $6.19 |
| 52 Week High | $19.39 | $13.16 |
Technical Indicators
Market Signals| Indicator | TRC | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | 47.14 |
| Support Level | $15.31 | $8.21 |
| Resistance Level | $15.95 | $8.70 |
| Average True Range (ATR) | 0.23 | 0.36 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 46.07 | 48.51 |
Price Performance
Historical ComparisonAbout TRC Tejon Ranch Co
Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely Real Estate - Commercial/Industrial, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.